The Effects of Minimal Shoes in Older People at Risk of Falls: The Feetback Shoe Study (FSS)

July 3, 2020 updated by: Tomasz Cudejko, University of Liverpool

Preventing Falls in Older People Using an Innovative Connected Shoe: Development & Biomechanics Study.

A third of people over 65, and half of people over 80, fall at least once a year. Falls are the most common cause of death from injury in the over 65s and result in a significant financial burden on the whole society. Shoes directly influence balance, gait, and the subsequent risk of slips, trips and falls by altering somatosensory feedback to the foot and ankle. Minimal shoes, that is shoes lacking a firm heel cup, a rigid sole or longitudinal arch support, have shown advantages in strengthening muscles and improving balance as compared to conventional shoes. However, limited research has studied the effect of minimal shoe in older people at risk of falls. The aim of the project will be to assess the effects of minimal shoes in older people at risk of falls, compared to conventional shoes and barefoot.

Study Overview

Detailed Description

Study participants will attend a one-day testing session at the Movement Laboratory, University of Liverpool. Participants will be subjected to several standing and walking tests while wearing three types of footwear in a randomised order: (i) a minimal shoe, (ii) a conventional shoe, and (iii) barefoot. Participants' physical function, stability during standing and walking and an activity of lower leg muscles will be assessed in each of those three footwear conditions. Participants will also be asked about perceptions of footwear, regarding a minimal shoe and a conventional shoe. At the end of assessments, participants will be asked to complete several walking bouts while wearing a minimal shoe with "smart" shoe insoles, to determine "smart" insoles' validity in obtaining gait characteristics against a gold standard measure. Finally, those participants who volunteer to take part in a two-week follow-up study, will be asked to wear the minimal shoes with "smart" insoles during daily life for two weeks, After two weeks, they will be asked to fill in an online questionnaire asking them about total time they used the minimal shoes and insoles and about how satisfied they were with them.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merseyside
      • Liverpool, Merseyside, United Kingdom, L8 0TL
        • University of Liverpool

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Community-dwelling older adults

Description

Inclusion Criteria:

  • Age: ≥ 60 years old
  • One of the vulnerability criteria for risk falls:

    (i) ≥ 1 self-reported falls after the age of 60; (ii) balance impairment as indicated by a score <45 on the Berg Balance Scale, by a score >2 on the simplified Tinetti Gait & Balance test or via any other validated and reliable clinical instrument used at the recruitment site; (iii) one or two criteria for physical frailty

Exclusion Criteria:

  • Macro-vascular symptoms (angina, stroke or a peripheral vascular disease)
  • Neuromuscular diseases (Multiple Sclerosis, Alzheimer Disease or Parkinson Disease)
  • Diabetes
  • Use of a walking aid (cane or walker)
  • Ankle, knee, hip surgery ≤ 3 months
  • Pain in the lower extremities of ≥ 8 on the numeric rating scale

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Older people at risk of falls
A minimal shoe (Vivobarefoot Ltd., London, UK) will be used.
The Go Walk 4.0-Pursuit shoe for women (Skechers USA, Inc.) and the Superior 2.0-Jeveno shoe for men (Skechers USA, Inc) will be used.
Participants will conduct the assessments barefoot.
Arion pressure-measuring insoles (Eindhoven, The Netherlands) will be used in the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up and Go test
Time Frame: First day of joining the study
Time (in seconds) to complete the Timed Up and Go test
First day of joining the study
Star Excursion Balance Test
Time Frame: First day of joining the study
Reach (in centimetres) to achieve during the Star Excursion Balance Test
First day of joining the study
Postural stability
Time Frame: First day of joining the study
Anterior-Posterior and latero-medial movement (in centimetres) of the centre of pressure
First day of joining the study
Dynamic stability
Time Frame: First day of joining the study
Variability (standard deviations) of spatio-temporal gait characteristics
First day of joining the study
Muscle activity
Time Frame: First day of joining the study
Electromyography activity for selected lower leg muscles and expressed in millivolts
First day of joining the study
Perceived attractiveness
Time Frame: First day of joining the study
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unattractive" and 100 mm being "extremely attractive"
First day of joining the study
Perceived attractiveness for others
Time Frame: First day of joining the study
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unattractive for others" and 100 mm being "extremely attractive for others"
First day of joining the study
Perceived comfort
Time Frame: First day of joining the study
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely uncomfortable" and 100 mm being "extremely comfortable"
First day of joining the study
Perceived weight
Time Frame: First day of joining the study
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely light" and 100 mm being "extremely heavy"
First day of joining the study
Perceived fit
Time Frame: First day of joining the study
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "poorest fit possible" and 100 mm being "best fit possible"
First day of joining the study
Perceived ease of use
Time Frame: First day of joining the study
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "most difficult as possible" and 100 mm being "as easy as imaginable"
First day of joining the study
Perceived stability
Time Frame: First day of joining the study
Scored on a 100-millimetres (mm) visual analogue scale with 0 mm being "extremely unstable" and 100 mm being "extremely stable"
First day of joining the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Validity of "smart" shoe insoles
Time Frame: First day of joining the study
Validity of Arion insoles against Qualisys Motion Capture System
First day of joining the study
Adherence to wearing minimal shoes in daily life
Time Frame: The assessment will be performed at 2 weeks
Adherence to wearing minimal shoes with "smart" shoe insoles assessed with an online questionnaire and expressed in total time in days and hours
The assessment will be performed at 2 weeks
Satisfaction of wearing minimal shoes in daily life
Time Frame: The assessment will be performed at 2 weeks
Satisfaction of wearing minimal shoes with "smart" shoe insoles assessed with an online questionnaire and expressed on a 5-point Likert scale, with the following levels: 1 - Very dissatisfied, 2 - dissatisfied, 3 - unsure, 4 - satisfied, 5 - Very satisfied.
The assessment will be performed at 2 weeks
Gait characteristics during daily life
Time Frame: The assessment will be performed at 2 weeks
Gait characteristics, assessed with "smart" shoe insoles, during activities of daily life and expressed in spatio-temporal metrics
The assessment will be performed at 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristiaan D'Août, PhD, University of Liverpool

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 20, 2019

Primary Completion (ACTUAL)

March 1, 2020

Study Completion (ACTUAL)

March 1, 2020

Study Registration Dates

First Submitted

March 12, 2019

First Submitted That Met QC Criteria

March 12, 2019

First Posted (ACTUAL)

March 14, 2019

Study Record Updates

Last Update Posted (ACTUAL)

July 7, 2020

Last Update Submitted That Met QC Criteria

July 3, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Minimal shoes

3
Subscribe